It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Skeletal development depends on coordinated angiogenesis and osteogenesis. Bone morphogenetic proteins direct bone formation in part by activating SMAD1/5 signaling in osteoblasts. However, the role of SMAD1/5 in skeletal endothelium is unknown. Here, we found that endothelial cell-conditional SMAD1/5 depletion in juvenile mice caused metaphyseal and diaphyseal hypervascularity, resulting in altered trabecular and cortical bone formation. SMAD1/5 depletion induced excessive sprouting and disrupting the morphology of the metaphyseal vessels, with impaired anastomotic loop formation at the chondro-osseous junction. Endothelial SMAD1/5 depletion impaired growth plate resorption and, upon long-term depletion, abrogated osteoprogenitor recruitment to the primary spongiosa. Finally, in the diaphysis, endothelial SMAD1/5 activity was necessary to maintain the sinusoidal phenotype, with SMAD1/5 depletion inducing formation of large vascular loops and elevated vascular permeability. Together, endothelial SMAD1/5 activity sustains skeletal vascular morphogenesis and function and coordinates growth plate remodeling and osteoprogenitor recruitment dynamics in juvenile mouse bone.
The intracellular effectors of bone morphogenetic protein signaling, SMAD1/5, act in skeleton-resident endothelial cells to direct bone formation in long bones of juvenile mice.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 University of Pennsylvania, Departments of Orthopaedic Surgery and Bioengineering, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972); corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639); Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden (TUD), Centre for Translational Bone, Joint and Soft Tissue Research, Dresden, Germany (GRID:grid.4488.0) (ISNI:0000 0001 2111 7257)
2 Center for Molecular and Vascular Biology, KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884); VIB-KU Leuven Center for Brain & Disease Research, KU Leuven, Leuven, Belgium (GRID:grid.511015.1)
3 University of Pennsylvania, Departments of Orthopaedic Surgery and Bioengineering, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
4 corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany (GRID:grid.7468.d) (ISNI:0000 0001 2248 7639); Freie Universität Berlin, Department of Veterinary Medicine, Institute of Animal Welfare, Animal Behavior and Laboratory Animal Science, Berlin, Germany (GRID:grid.14095.39) (ISNI:0000 0000 9116 4836)
5 Materials and Civil Engineering, Biomechanics lab, UCLouvain, Institute of Mechanics, Louvain-la-Neuve, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); Pole of Morphology, UCLouvain, Institute of Experimental and Clinical Research, Brussels, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); Sustainable Chemistry for Metals and Molecules, KU Leuven, Department of Chemistry, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
6 Materials and Civil Engineering, Biomechanics lab, UCLouvain, Institute of Mechanics, Louvain-la-Neuve, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); Pole of Morphology, UCLouvain, Institute of Experimental and Clinical Research, Brussels, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); KU Leuven, Department of Materials Engineering, Heverlee, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884); Division for Skeletal Tissue Engineering, Prometheus, KU Leuven, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)
7 Center for Molecular and Vascular Biology, KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884)